Advances in clinical chemistry. Volume 74 /
Advances in Clinical Chemistry, Volume 75, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists. This serial discusses the latest and most up-to-date technologies related to t...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Cambridge, MA :
Academic Press is an imprint of Elsevier,
2016.
|
Temas: | |
Acceso en línea: | Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn948156823 | ||
003 | OCoLC | ||
005 | 20231120112105.0 | ||
006 | m o d | ||
007 | cr nn|---aucuu | ||
008 | 160428s2016 mau ob 001 0 eng d | ||
040 | |a OPELS |b eng |e rda |e pn |c OPELS |d OPELS |d N$T |d UIU |d N$T |d D6H |d UKBTH |d WURST |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
020 | |a 9780128048405 |q (electronic bk.) | ||
020 | |a 0128048409 |q (electronic bk.) | ||
020 | |z 9780128046890 | ||
020 | |z 0128046899 | ||
035 | |a (OCoLC)948156823 | ||
050 | 4 | |a RB40 | |
072 | 7 | |a HEA |x 039000 |2 bisacsh | |
072 | 7 | |a MED |x 014000 |2 bisacsh | |
072 | 7 | |a MED |x 022000 |2 bisacsh | |
072 | 7 | |a MED |x 112000 |2 bisacsh | |
072 | 7 | |a MED |x 045000 |2 bisacsh | |
082 | 0 | 4 | |a 616.07/56 |2 23 |
245 | 0 | 0 | |a Advances in clinical chemistry. |n Volume 74 / |c edited by Gregory S. Makowski. |
264 | 1 | |a Cambridge, MA : |b Academic Press is an imprint of Elsevier, |c 2016. | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
504 | |a Includes bibliographical references and index. | ||
588 | 0 | |a Online resource; title from PDF title page (ScienceDirect, viewed April 28, 2016). | |
505 | 0 | |a Front Cover; Advances in Clinical Chemistry; Copyright; Contents; Contributors; Preface; Chapter One: Capillary Electrophoresis-Mass Spectrometry for Clinical Metabolomics; 1. Introduction; 2. CE-MS Methodology; 2.1. CE Modes and Separation Conditions; 2.2. Interfacing Aspects of CE-MS; 3. Clinical Metabolomics; 3.1. General Aspects; 3.2. Strategies for Data Analysis; 3.3. Applications; 4. Conclusions and Perspectives; Acknowledgments; References; Chapter Two: Metabolomics in Newborns; 1. Introduction; 2. Data Analysis in Metabolomics; 3. Metabolomics in Neonatology; 3.1. Prematurity | |
505 | 8 | |a 3.2. Intrauterine Growth Retardation3.3. Inborn Errors of Metabolism; 3.4. Perinatal Asphyxia; 3.5. Sepsis; 3.6. Necrotizing Enterocolitis; 3.7. Kidney Disease; 3.8. Bronchopulmonary Dysplasia; 3.9. Cardiac Malformation and Dysfunction; 4. Conclusions; References; Chapter Three: Maternal Plasma DNA and RNA Sequencing for Prenatal Testing; 1. Introduction; 2. History; 2.1. Why Prenatal Screening for Aneuploidy?; 2.2. History of Invasive Prenatal Screening; 2.3. History of Noninvasive Prenatal Screening; 2.4. History of NIPT; 3. Background of NIPT | |
505 | 8 | |a 4. Different Techniques and Bioinformatic Approaches4.1. The z-Score and Its Rationale to Determine Fetal Aneuploidies; 4.2. Whole-Genome Approach; 4.3. Targeted Approach; 4.4. Fetal Fraction Determination; 5. Biological Difficulties; 5.1. Reasons for False-Negative Results; 5.1.1. Low Fetal Fraction; 5.1.2. True Fetal Mosaicism; 5.1.3. Twin Pregnancies; 5.2. Reasons for False-Positive Results; 5.2.1. Confined Placental Mosaicism; 5.2.2. Maternal Findings: Chromosomal Abnormalities; 5.2.3. Maternal Findings: Malignancy; 5.2.4. Vanishing Twin; 6. Technical Difficulties | |
505 | 8 | |a 7. Clinical Implementation7.1. Current Use of NIPT in a Diagnostic Setting; 7.2. Population-Based Screening; 7.3. Pretest Counseling; 7.4. Changes in Prenatal Diagnosis and Screening; 8. Ethical Aspects; 9. Professional Policy Statements; 10. Future Perspectives of Cell-free DNA Testing; 10.1. The Molecular Stethoscope; 10.2. Different Stores: Different Products on the Shelf; 10.3. Genome-Wide RNA Profiling in Pregnancy; 10.3.1. MicroRNA Profiling of Plasma in Pregnant Women; 10.3.2. Genome-Wide RNA Profiling of Plasma in Pregnant Women | |
505 | 8 | |a 10.3.3. Genome-Wide RNA Profiling of Plasma of Pregnant Women with Preeclampsia10.4. Genome-Wide RNA Profiling of Circulating Platelets in Cancer: Consequences for Prenatal Testing; 11. Conclusions; Acknowledgments; References; Chapter Four: Tumor-Derived Exosomes and Their Role in Cancer Progression; 1. Introduction; 2. Exosome Biogenesis in Cancer; 3. Morphology and Molecular Content of Tumor-Derived Exosomes; 4. Communication of Tumor-Derived Exosomes with Their Cell Targets; 5. Biological Functions of Tumor-Derived Exosomes; 6. Methods Available for Studies of Tumor-Derived Exosomes | |
520 | 3 | |a Advances in Clinical Chemistry, Volume 75, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians, and research scientists. This serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry and is the benchmark for novel analytical approaches in the clinical laboratory. | |
650 | 0 | |a Clinical chemistry. | |
650 | 2 | |a Chemistry, Clinical |0 (DNLM)D002624 | |
650 | 6 | |a Chimie clinique. |0 (CaQQLa)201-0016714 | |
650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
650 | 7 | |a Clinical chemistry |2 fast |0 (OCoLC)fst00864330 | |
700 | 1 | |a Makowski, Gregory S. |q (Gregory Stephen), |e editor. | |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128046890 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652423/74 |z Texto completo |